Aberrant methylation of the M-type phospholipase A2 receptor gene in leukemic cells

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Menschikowski, Mario ^a   Platzbecker, Uwe ^a   Hagelgans, Albert ^a   Vogel, Margot ^a   Thiede, Christian ^a   Schönefeldt, Claudia ^a   Lehnert, Renate ^a   Eisenhofer, Graeme ^a   Siegert, Gabriele ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

DNA methylation; High resolution melting analysis; Leukemia; Phospholipase A2 receptor

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; M TYPE PHOSPHOLIPASE A2 RECEPTOR; PHOSPHOLIPASE A2 RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL; MALE; METHYLATION; MYELODYSPLASTIC SYNDROME; PLA2R1 GENE; PRESCHOOL CHILD; PROMOTER REGION; PROTEIN EXPRESSION; SCHOOL CHILD; TREATMENT RESPONSE;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; DNA METHYLATION; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JURKAT CELLS; LEUKEMIA; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RECEPTORS, PHOSPHOLIPASE A2; U937 CELLS; YOUNG ADULT;

EID: 84870331190     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-576     Document Type: Article

References (33)

1. Waite M. The Phospholipases 1987, Plenum Press, New York.
2. Dennis EA, Deems RA, Yu L. Extracellular phospholipase A2. Adv Exp Med Biol 1992, 318:35-39. 10.1007/978-1-4615-3426-6_4, 1636503.
3. Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 2002, 68-69:3-58. 3520445, 23041291.
4. Menschikowski M, Hagelgans A, Siegert G. Secretory phospholipase A2 of group IIA: Is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?. Prostaglandins Other Lipid Mediat 2006, 79:1-33. 10.1016/j.prostaglandins.2005.10.005, 16516807.
5. Triggiani M, Granata F, Balestrieri B, Petraroli A, Scalia G, Del Vecchio L, Marone G. Secretory phospholipases A2 activate selective functions in human eosinophils. J Immunol 2003, 170:3279-3288.
6. Saegusa J, Akakura N, Wu CY, Hoogland C, Ma Z, Lam KS, Liu FT, Takada YK, Takada Y. Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner. J Biol Chem 2008, 283:26107-26115. 10.1074/jbc.M804835200, 2533795, 18635536.
7. Yagami T, Ueda K, Asakura K, Nakazato H, Hata S, Kuroda T, Sakaeda T, Sakaguchi G, Itoh N, Hashimoto Y, Hori Y. Human group IIA secretory phospholipase A2 potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels in cultured rat cortical neurons. J Neurochem 2003, 85:749-758. 10.1046/j.1471-4159.2003.01712.x, 12694401.
8. Yagami T, Ueda K, Asakura K, Hata S, Kuroda T, Sakaeda T, Kishino J, Sakaguchi G, Itoh N, Hori Y. Group IB secretory phospholipase A2 induces cell death in the cultured cortical neurons: a possible involvement of its binding sites. Brain Res 2002, 949:197-201. 10.1016/S0006-8993(02)03144-X, 12213316.
9. Lambeau G, Barhanin J, Schweitz H, Qar J, Lazdunski M. Identification and properties of very high affinity brain membrane-binding sites for a neurotoxic phospholipase from the taipan venom. J Biol Chem 1989, 264:11503-11510.
10. Hanasaki K, Arita H. Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2. Prostaglandins Other Lipid Mediat 2002, 68-69:71-82. 3520445, 23041291.
11. Hanasaki K, Arita H. Biological and pathological functions of phospholipase A2 receptor. Arch Biochem Biophys 1999, 372:215-223. 10.1006/abbi.1999.1511, 10600158.
12. Taylor ME, Conary JT, Lennartz MR, Stahl PD, Drickamer K. Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains. J Biol Chem 1990, 265:12156-12162.
13. Valentin E, Lambeau G. Increasing molecular diversity of secreted phospholipases A2 and their receptors and binding proteins. Biochim Biophys Acta 2000, 1488:59-70. 10.1016/S1388-1981(00)00110-4, 11080677.
14. Beck LH, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ. M-Type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009, 361:11-21. 10.1056/NEJMoa0810457, 2762083, 19571279.
15. Platzbecker U, Wermke M, Radke J, Oelschlaegel U, Seltmann F, Kiani A, Klut IM, Knoth H, Röllig C, Schetelig J, Mohr B, Graehlert X, Ehninger G, Bornhäuser M, Thiede C. Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial. Leukemia 2012, 26:381-389. 10.1038/leu.2011.234, 3306138, 21886171.
16. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002, 18:1427-1431. 10.1093/bioinformatics/18.11.1427, 12424112.
17. Frommer ML, McDonald E, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. P Natl Acad Sci USA 1991, 89:1827-1831.
18. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994, 22:2990-2997. 10.1093/nar/22.15.2990, 310266, 8065911.
19. Warnecke PM, Stirzaker C, Song J, Grunau C, Melki JR, Clark SJ. Identification and resolution of artifacts in bisulfite sequencing. Methods 2002, 27:101-107. 10.1016/S1046-2023(02)00060-9, 12095266.
20. Kim HJ, Kim KS, Kim SH, Baek SH, Kim HY, Lee C, Kim JR. Induction of cellular senescence by secretory phospholipase A2 in human dermal fibroblasts through an ROS-mediated p53 pathway. J Gerontol A Biol Sci Med Sci 2009, 64:351-362. 2654997, 19264704.
21. Augert A, Payré C, de Launoit Y, Gil J, Lambeau G, Bernard D. The M-type receptor PLA2R1 regulates senescence through the p53 pathway. EMBO Rep 2009, 10:271-277. 10.1038/embor.2008.255, 2658567, 19197340.
22. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dörken B, Jenuwein T, Schmitt CA. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005, 436:660-665. 10.1038/nature03841, 16079837.
23. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, Cordon-Cardo C, Pandolfi PP. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005, 436:725-730. 10.1038/nature03918, 1939938, 16079851.
24. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013, 21376230.
25. Jiang Y, Dunbar A, Gondek LP, Mohan S, Rataul M, O'Keefe C, Sekeres M, Saunthararajah Y, Maciejewski JP. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. Blood 2009, 113:1315-1325. 10.1182/blood-2008-06-163246, 2637194, 18832655.
26. Follo MY, Finelli C, Mongiorgi S, Clissa C, Bosi C, Testoni N, Chiarini F, Ramazzotti G, Baccarani M, Martelli AM, Manzoli L, Martinelli G, Cocco L. Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. Proc Natl Acad Sci USA 2009, 106:16811-16816. 10.1073/pnas.0907109106, 2741479, 19805378.
27. Costa-Junior HM, Hamaty FC. da Silva Farias R, Einicker-Lamas M, da Silva MH, Persechini PM. Apoptosis-inducing factor of a cytotoxic T cell line: involvement of a secretory phospholipase A2. Cell Tissue Res 2006, 324:255-266. 10.1007/s00441-005-0095-y, 16609916.
28. Lee C, Park DW, Lee J, Lee TI, Kim YJ, Lee YS, Baek SH. Secretory phospholipase A2 induces apoptosis through TNF-α and cytochrome c-mediated caspase cascade in murine macrophage RAW 264.7 cells. Eur J Pharmacol 2006, 536:47-53. 10.1016/j.ejphar.2006.02.043, 16564042.
29. Mora R, Maldonado A, Valverde B, Gutiérrez JM. Calcium plays a key role in the effects induced by a snake venom Lys49 phospholipase A2 homologue on a lymphoblastoid cell line. Toxicon 2006, 47:75-86. 10.1016/j.toxicon.2005.10.001, 16303159.
30. Petrovic U, Sribar J, Matis M, Anderluh G, Peter-Katalinić J, Krizaj I, Gubensek F. Ammodytoxin, a secretory phospholipase A2, inhibits G2 cell-cycle arrest in the yeast Saccharomyces cerevisiae. Biochem J 2005, 391:383-388. 10.1042/BJ20050417, 1276937, 16008522.
31. Putz T, Ramoner R, Gander H, Rahm A, Bartsch G, Bernardo K, Ramsay S, Thurnher M. Bee venom secretory phospholipase A2 and phosphatidylinositol-homologues cooperatively disrupt membrane integrity, abrogate signal transduction and inhibit proliferation of renal cancer cells. Cancer Immunol Immunother 2007, 56:627-640. 10.1007/s00262-006-0220-0, 16947021.
32. Hanasaki K, Yokota Y, Ishizaki J, Itoh T, Arita H. Resistance to endotoxic shock in phospholipase A2 receptor-deficient mice. J Biol Chem 1997, 272:32792-32797. 10.1074/jbc.272.52.32792, 9407054.
33. Lambeau G, Lazdunski M. Receptors for a growing family of secreted phospholipases A2. Trends Pharmacol Sci 1999, 20:162-170. 10.1016/S0165-6147(99)01300-0, 10322502.